Long-term outcome of neuroparacoccidioidomycosis treatment

INTRODUCTION: Neuroparacoccidioidomycosis (NPCM) is a term used to describe the invasion of the central nervous system by the pathogenic fungus Paracoccidioides brasiliensis. NPCM has been described sporadically in some case reports and small case series, with little or no focus on treatment outcome...

Full description

Bibliographic Details
Main Authors: Fabio Francesconi, Marcus Tulius Teixeira da Silva, Regina Lana Braga Costa, Valeska Albuquerque Francesconi, Eleonora Carregal, Sinésio Talhari, Antonio Carlos Francesconi do Valle
Format: Article
Language:English
Published: Sociedade Brasileira de Medicina Tropical (SBMT) 2011-02-01
Series:Revista da Sociedade Brasileira de Medicina Tropical
Subjects:
Online Access:http://www.scielo.br/scielo.php?script=sci_arttext&pid=S0037-86822011000100006&lng=en&tlng=en
_version_ 1811245759964643328
author Fabio Francesconi
Marcus Tulius Teixeira da Silva
Regina Lana Braga Costa
Valeska Albuquerque Francesconi
Eleonora Carregal
Sinésio Talhari
Antonio Carlos Francesconi do Valle
author_facet Fabio Francesconi
Marcus Tulius Teixeira da Silva
Regina Lana Braga Costa
Valeska Albuquerque Francesconi
Eleonora Carregal
Sinésio Talhari
Antonio Carlos Francesconi do Valle
author_sort Fabio Francesconi
collection DOAJ
description INTRODUCTION: Neuroparacoccidioidomycosis (NPCM) is a term used to describe the invasion of the central nervous system by the pathogenic fungus Paracoccidioides brasiliensis. NPCM has been described sporadically in some case reports and small case series, with little or no focus on treatment outcome and long-term follow-up. METHODS: All patients with NPCM from January 1991 to December 2006 were analyzed and were followed until December 2009. RESULTS: Fourteen (3.8%) cases of NPCM were identified out of 367 patients with paracoccidioidomycosis (PCM). A combination of oral fluconazole and sulfamethoxazole/trimethoprim (SMZ/TMP) was the regimen of choice, with no documented death due to Paracoccidioides brasiliensis infection. Residual neurological deficits were observed in 8 patients. Residual calcification was a common finding in neuroimaging follow-up. CONCLUSIONS: All the patients in this study responded positively to the association of oral fluconazole and sulfamethoxazole/trimethoprim, a regimen that should be considered a treatment option in cases of NPCM. Neurological sequela was a relatively common finding. For proper management of these patients, anticonvulsant treatment and physical therapy support were also needed.
first_indexed 2024-04-12T14:43:07Z
format Article
id doaj.art-11f2f8ed541146108a33ae522c603b96
institution Directory Open Access Journal
issn 1678-9849
language English
last_indexed 2024-04-12T14:43:07Z
publishDate 2011-02-01
publisher Sociedade Brasileira de Medicina Tropical (SBMT)
record_format Article
series Revista da Sociedade Brasileira de Medicina Tropical
spelling doaj.art-11f2f8ed541146108a33ae522c603b962022-12-22T03:28:44ZengSociedade Brasileira de Medicina Tropical (SBMT)Revista da Sociedade Brasileira de Medicina Tropical1678-98492011-02-01441222510.1590/S0037-86822011000100006S0037-86822011000100006Long-term outcome of neuroparacoccidioidomycosis treatmentFabio Francesconi0Marcus Tulius Teixeira da Silva1Regina Lana Braga Costa2Valeska Albuquerque Francesconi3Eleonora Carregal4Sinésio Talhari5Antonio Carlos Francesconi do Valle6Manaus Oncology Control Foundation CenterFundação Oswaldo CruzFundação Oswaldo CruzManaus Oncology Control Foundation CenterFundação Oswaldo CruzFundação de Medicina Tropical do AmazonasFundação Oswaldo CruzINTRODUCTION: Neuroparacoccidioidomycosis (NPCM) is a term used to describe the invasion of the central nervous system by the pathogenic fungus Paracoccidioides brasiliensis. NPCM has been described sporadically in some case reports and small case series, with little or no focus on treatment outcome and long-term follow-up. METHODS: All patients with NPCM from January 1991 to December 2006 were analyzed and were followed until December 2009. RESULTS: Fourteen (3.8%) cases of NPCM were identified out of 367 patients with paracoccidioidomycosis (PCM). A combination of oral fluconazole and sulfamethoxazole/trimethoprim (SMZ/TMP) was the regimen of choice, with no documented death due to Paracoccidioides brasiliensis infection. Residual neurological deficits were observed in 8 patients. Residual calcification was a common finding in neuroimaging follow-up. CONCLUSIONS: All the patients in this study responded positively to the association of oral fluconazole and sulfamethoxazole/trimethoprim, a regimen that should be considered a treatment option in cases of NPCM. Neurological sequela was a relatively common finding. For proper management of these patients, anticonvulsant treatment and physical therapy support were also needed.http://www.scielo.br/scielo.php?script=sci_arttext&pid=S0037-86822011000100006&lng=en&tlng=enParacoccidioides brasiliensisNeuroparacoccidioidomicoseTratamentoInfecção do sistema nervoso central
spellingShingle Fabio Francesconi
Marcus Tulius Teixeira da Silva
Regina Lana Braga Costa
Valeska Albuquerque Francesconi
Eleonora Carregal
Sinésio Talhari
Antonio Carlos Francesconi do Valle
Long-term outcome of neuroparacoccidioidomycosis treatment
Revista da Sociedade Brasileira de Medicina Tropical
Paracoccidioides brasiliensis
Neuroparacoccidioidomicose
Tratamento
Infecção do sistema nervoso central
title Long-term outcome of neuroparacoccidioidomycosis treatment
title_full Long-term outcome of neuroparacoccidioidomycosis treatment
title_fullStr Long-term outcome of neuroparacoccidioidomycosis treatment
title_full_unstemmed Long-term outcome of neuroparacoccidioidomycosis treatment
title_short Long-term outcome of neuroparacoccidioidomycosis treatment
title_sort long term outcome of neuroparacoccidioidomycosis treatment
topic Paracoccidioides brasiliensis
Neuroparacoccidioidomicose
Tratamento
Infecção do sistema nervoso central
url http://www.scielo.br/scielo.php?script=sci_arttext&pid=S0037-86822011000100006&lng=en&tlng=en
work_keys_str_mv AT fabiofrancesconi longtermoutcomeofneuroparacoccidioidomycosistreatment
AT marcustuliusteixeiradasilva longtermoutcomeofneuroparacoccidioidomycosistreatment
AT reginalanabragacosta longtermoutcomeofneuroparacoccidioidomycosistreatment
AT valeskaalbuquerquefrancesconi longtermoutcomeofneuroparacoccidioidomycosistreatment
AT eleonoracarregal longtermoutcomeofneuroparacoccidioidomycosistreatment
AT sinesiotalhari longtermoutcomeofneuroparacoccidioidomycosistreatment
AT antoniocarlosfrancesconidovalle longtermoutcomeofneuroparacoccidioidomycosistreatment